Vaccination of immunocompromised or immunosuppressed people against COVID is a major topic now.
I think this is good simple advice:
"Get vaccinated, but behave as though you're not," Dorlan Kimbrough, a neurologist who treats multiple sclerosis patients at Duke. 🧵
It is early days for understanding and advice on this, but thankfully there are already scientific studies (preprints) being published on COVID vaccine immune responses in such patients. These are two good new news articles on the topic: advisory.com/en/daily-brief…
Importantly, immunocompromised/immunosuppressed is a diverse range. Many have will make fine immune responses to COVID-19 vaccines. So the specific condition/medical treatments matter. Remicade/infliximab and glucocortocoid treatment result in reduced vaccine antibody responses.
Somewhat surprisingly, B-cell CLL patients had low responses. Organ transplant patients and people on B cell depletion therapies have the most severe reduction of vaccine antibody responses, as expected.
Sadly, no T cell data available from any of these studies. Thus, is unclear if people with weak antibodies are still making T cells (which prob varies depending on patient condition), and whether those T cells provide substantial or partial protection against serious COVID
Thus, as noted at the beginning of the thread, the best advice for now is get vaccinated but then behave as if you haven't been vaccinated. In the near future, it may be determined that some people need another booster immunization
Cases like this will become more common:
Here's an immunocompromised doctor who took 2 doses of RNA vaccine and then 1 dose of J&J. medpagetoday.com/special-report…
People are starting vaccine clinical trials like this for immunocompromised/immunosuppressed people.
Related, in the near future, it may be determined that some people who completely fail to respond to the vaccine will need continuous prophylactic monoclonal antibody therapy.
“The fact that there is real-world data that shows the Pfizer vaccine works very well against the South African variant, it's quite likely that both the Pfizer and Moderna vaccines will be very effective against these new Indian variants, as well,”
That is based on:
🔵 data from Qatar against B1351 (97% protection against severe disease, 75% against infection)
🔵@SutharLab B1617 neutralizing Ab data
🔵L452R containing CAL.C20 variant antibody data
Overall, this new delayed dose vaccine study it is a high quality study. Bottom lines:
🔵 The UK delayed vaccination is working for them, and allows vaccination of more people. And the new data support that. I am really happy about that!
🔵 But, if you have enough doses, getting the 2nd dose on the recommended schedule is still probably better.
The FDA expanded the Pfizer/BioNTech RNA COVID-19 vaccine to 12-15 year olds yesterday.
🔵Excellent protection (100% = 0 cases versus 18)
🔵Excellent safety (On to younger children already)
🔵Better antibodies than adults
Also bodes well for other COVID vaccines in kids!🧵
FDA CBER head Dr. Marks:"It was a relatively straightforward decision. The response..was excellent and in fact it was even better, really, in the younger age group than it was in the 16-25 age group. The safety profile was very similar in 12-15-year-olds as in 16-25-year-olds."
Moderna results are out for their booster vaccines!
🔵 Boosting with same vaccine generates good antibodies against variant B.1.351
🔵 Boosting with a B.1.351 vaccine generates even better antibodies
🔵 Safe
🔵 The booster vaccine was made and tested with exceptional speed!
🧵
The reason for excitement about this is that there has been uncertainly for months about vaccine efficacy against B.1.351 (1st seen in South Africa) and similar variants. Since January I have been saying:
Moderna, Pfizer, J&J and other vaccine companies have all stated that they are developing B.1.351 boosters or similar. Today is the first public data on such a vaccine.
Big knowledge gap was will the COVID RNA vaccines work vs B.1.351 and P.1 variants. Now Pfizer protects well vs B.1.351!
🔵 ~75% against infection
🔵 ~97% against severe/fatal disease
Very good news for the rest of 2021 for any countries using Pfizer and Moderna vaccines! 🧵
B.1.351 and P.1 (1st found in South Africa and Brazil) have been the two biggest variants of concern that have a degree of antibody escape. As of this morning (and February), some vaccines (AZ) showed only 11% effectiveness against B.1.351 cases,
and the best clinical trial data was ~50-66% vaccine efficacy against B.1.351 cases (J&J and Novavax), and only data for non-hospitalized cases (because of the size of the studies). Leaving lots of uncertainty.